Related Experiment Video
Updated: Sep 12, 2025

Viability Assays for Cells in Culture
Published on: January 20, 2014
Hormesis and cancer therapy
Glaucia Maria Machado-Santelli1, Julyane Batista Chaves1
1Departamento De Biologia Celular e do Desenvolvimento, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, SP, Brazil.
Abstract:
Hormesis, the processes in which small doses of a stressor show stimulatory effects or protective responses on target cells, and high doses show the opposite effects, was described as associated with cancer therapy. Although the introduction of new techniques in cancer therapy improved the success rate and patients' survival, it is important to mainly focus on chemo and radiotherapy. Some examples illustrating the hormetic relationships with cancer therapy are described. The hormetic response in cancer therapy presents considerable complexity due to the wide variability in biological responses observed between different systems and conditions. This variability poses significant challenges for the practical implementation of hormesis in oncological settings. Nevertheless, its potential to optimize existing therapies positions this phenomenon as an area of great interest and relevance for future scientific investigations.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Mitogens and the Cell Cycle
Targeted Cancer Therapies
There are several types of targeted therapies against...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Tumor Immunotherapy

